
2026-10-16
Crystalline hydroxyapatite is a high-purity, bioactive calcium phosphate compound widely utilized in advanced medical aesthetics and cosmetic formulations. As a premier supplier, Jinan Meiyi Biotechnology Co., Ltd. provides rigorously vetted, OEM-ready crystalline hydroxyapatite sourced from certified global manufacturers. Our supply chain ensures strict adherence to international quality standards, offering R&D laboratories and CDMOs reliable access to this critical ingredient for skin rejuvenation, bone regeneration, and dental applications. We prioritize technical transparency, regulatory compliance, and consistent batch stability to support innovative bioactive product development.
Crystalline hydroxyapatite (HA), chemically represented as Ca10(PO4)6(OH)2, is the primary mineral component of human bone and tooth enamel. In its synthetic, crystalline form, it serves as a highly biocompatible and bioactive material. Unlike amorphous variants, crystalline HA possesses a structured lattice that offers superior stability, predictable degradation rates, and enhanced mechanical strength.
For formulators in the cosmetics and medical device sectors, the degree of crystallinity is a critical parameter. High crystallinity correlates with slower resorption rates in biological environments, making it ideal for long-term volumizing effects in soft tissue augmentation or sustained release matrices in topical skincare. The material’s surface chemistry allows for strong bonding with living tissue, a property known as osteoconductivity, which is equally valuable in dermatological applications for stimulating collagen synthesis and tissue repair.

Sourcing high-performance raw materials requires more than just finding a supplier; it demands a partner who understands the intersection of scientific rigor and market responsiveness. Jinan Meiyi Biotechnology Co., Ltd., headquartered in Jinan, Shandong Province, operates as a specialized strategic sourcing and quality-assured distribution partner. As a subsidiary of Pacific Kangtai Scientific Instruments (Jinan) Co., Ltd., we leverage a robust global network to connect R&D-driven clients with top-tier manufacturing capabilities.
We do not engage in direct manufacturing. Instead, we function as a critical quality filter and logistics optimizer. Our model is built on partnering exclusively with certified manufacturers who adhere to internationally accepted quality management systems. This approach allows us to offer crystalline hydroxyapatite that is technically advanced, regulatory-compliant, and scientifically validated, without the overhead and variability often associated with managing multiple direct factory relationships.
Trustworthiness in the bioactive supply chain is established through transparency and documentation. Every batch of crystalline hydroxyapatite distributed by Jinan Meiyi Biotechnology undergoes a comprehensive evaluation process. Our quality assurance framework centers on four pillars:
The versatility of crystalline hydroxyapatite makes it a cornerstone ingredient in modern aesthetic medicine and high-performance skincare. Its ability to mimic natural bone mineral structure while providing structural support has led to its adoption in diverse formulations. Jinan Meiyi Biotechnology supports clients in developing products across several key application areas.
In medical aesthetics, micro-particles of crystalline hydroxyapatite are suspended in a carboxymethylcellulose (CMC) gel carrier. This formulation serves as a semi-permanent dermal filler. Upon injection, the gel carrier provides immediate volume, while the HA microspheres act as a scaffold for neocollagenesis. Over time, the body naturally replaces the carrier with new collagen, resulting in long-lasting tissue restoration. The high crystallinity of the HA particles ensures they maintain their structure during the integration phase, providing predictable and durable outcomes for patients seeking facial contouring and volume correction.
Beyond injectables, nano-crystalline hydroxyapatite is increasingly used in premium skincare products. Its small particle size allows for effective penetration into the stratum corneum, where it can deliver calcium ions to support barrier function and cellular communication. In anti-aging serums and creams, HA acts as a biomimetic agent, signaling fibroblasts to increase collagen and elastin production. This application aligns with the growing consumer demand for “science-backed” skincare that offers visible structural improvements rather than just surface hydration.
While our primary focus is cosmetics and aesthetics, the foundational technology of crystalline hydroxyapatite extends to dental and orthopedic applications. In these fields, larger granules or porous blocks of HA are used as bone graft substitutes. The material’s osteoconductive properties allow bone cells to migrate and grow along its surface, facilitating natural healing. For clients developing hybrid aesthetic-dental products, our supply chain offers access to varying grades of HA suitable for these specialized biomedical uses.
Selecting the right grade of crystalline hydroxyapatite depends on the intended application, delivery method, and desired biological response. Jinan Meiyi Biotechnology provides detailed technical consultation to help R&D teams match material properties with formulation goals. Below is a comparative overview of common specifications available through our network.
| Parameter | Micro-Crystalline HA (Injectable Grade) | Nano-Crystalline HA (Topical Grade) | Macro-Crystalline HA (Bone/Dental Grade) |
|---|---|---|---|
| Particle Size | 25–45 microns | < 100 nanometers | 100–1000 microns |
| Crystallinity Index | > 95% | > 90% | > 98% |
| Primary Application | Dermal fillers, volumizing | Serums, creams, barrier repair | Bone grafts, dental implants |
| Resorption Rate | Slow (12–18 months) | Metabolized via cellular uptake | Very Slow (Years) |
| Carrier Compatibility | CMC gel, Hyaluronic Acid | Aqueous solutions, emulsions | Scaffolds, cements |
When integrating crystalline hydroxyapatite into your product line, consider the following technical factors:
In the complex landscape of global bioactive trade, Jinan Meiyi Biotechnology offers distinct advantages over traditional trading companies or direct factory engagements. Our operational model is designed to reduce sourcing complexity while maintaining full confidence in material consistency and regulatory readiness.
We leverage a well-established global supply chain network to secure materials that might otherwise be difficult to access due to geopolitical or logistical barriers. By maintaining long-term partnerships with internationally recognized suppliers, we ensure a steady flow of high-performance raw materials. This reliability is critical for CDMOs and manufacturers who operate on tight production schedules and cannot afford supply chain disruptions.
Navigating the regulatory landscapes of Asia, Europe, and North America requires up-to-date knowledge. Jinan Meiyi Biotechnology actively monitors emerging trends in bioactive ingredient science and regulatory frameworks. We provide clients with regulatory intelligence sharing, helping them understand the compliance status of crystalline hydroxyapatite in target markets. This proactive approach minimizes the risk of regulatory hurdles during product registration and market entry.
Our service philosophy is rooted in partnership rather than transaction. We offer technical consultation and collaborative problem-solving as integral parts of client engagement. Whether you are troubleshooting a formulation stability issue or seeking advice on optimal particle size for a new injector design, our scientifically trained team is equipped to provide actionable insights. This level of support transforms us from a simple vendor into a strategic enabler of your innovation process.
Crystalline hydroxyapatite has a highly ordered atomic structure, making it more stable and slower to degrade in the body compared to amorphous hydroxyapatite, which lacks long-range order. Crystalline HA is preferred for applications requiring long-term structural support, such as dermal fillers and bone grafts, while amorphous HA is often used where faster resorption and ion release are desired.
Yes, high-purity crystalline hydroxyapatite is considered safe for cosmetic and medical aesthetic use when sourced from reputable manufacturers and processed under strict quality controls. It is biocompatible and bioactive, meaning it integrates well with human tissue without triggering significant immune responses. Jinan Meiyi Biotechnology ensures all supplied materials come with comprehensive safety data and regulatory documentation.
As a strategic sourcing partner, we work closely with our certified manufacturing partners to meet specific client requirements. While we do not manufacture directly, we can facilitate requests for custom particle size distributions or specific crystallinity indices by leveraging our network’s capabilities. Contact our technical team to discuss your specific formulation needs.
Every shipment of crystalline hydroxyapatite from Jinan Meiyi Biotechnology includes a full technical dossier. This typically comprises a Certificate of Analysis (CoA) detailing batch-specific parameters, a Safety Data Sheet (SDS) for handling and storage guidance, and relevant regulatory status summaries. Additional documents, such as stability data or biocompatibility reports, can be provided upon request.
In dermal applications, micro-particles of crystalline HA act as a physical scaffold. This scaffold triggers a mild, controlled inflammatory response that recruits fibroblasts to the site. These cells then produce new collagen and elastin fibers around the HA particles. Over time, as the carrier gel is absorbed, the newly formed collagen network remains, providing natural-looking volume and skin tightening.

The demand for science-backed, effective aesthetic solutions continues to grow globally. Crystalline hydroxyapatite stands out as a premier ingredient for achieving long-lasting, natural-looking results in both injectable and topical formulations. However, the quality of the final product is directly dependent on the purity, consistency, and regulatory compliance of the raw material.
Jinan Meiyi Biotechnology Co., Ltd. is positioned to support your success in this competitive market. By combining deep specialization in bioactive technology applications with a globally integrated and vetted supply chain, we provide more than just materials—we deliver confidence. Our disciplined curation methodology ensures that every gram of crystalline hydroxyapatite you receive meets the highest standards of efficacy and safety.
Whether you are an R&D laboratory developing next-generation dermal fillers, a CDMO scaling production for international brands, or an aesthetic clinic seeking differentiated solutions, our partnership-oriented service model is designed to meet your needs. We invite you to leverage our expertise, regulatory intelligence, and reliable supply network to accelerate your product development timeline.
Ready to optimize your formulation with high-purity crystalline hydroxyapatite?
Contact Jinan Meiyi Biotechnology today to request technical datasheets, sample information, or a customized supply proposal. Let us bridge the gap between upstream innovation and your downstream commercial success.
Explore our full range of bioactive raw materials and technical solutions